Valuation: Phaarmasia Limited

Market Cap 601M 6.26M 5.46M 5.16M 4.68M 8.77M 8.81M 61.75M 23.83M 305M 23.52M 23M 983M P/E 2025
-12.6x
P/E 2026 2.92x
Enterprise Value 504M 5.25M 4.58M 4.32M 3.93M 7.35M 7.39M 51.78M 19.98M 256M 19.72M 19.28M 824M EV / Sales 2025
0.81x
EV / Sales 2026 0.88x
Free-Float
-
Yield 2025 *
-
Yield 2026 -
1 day-1.12%
1 week+2.09%
Current month-12.02%
1 month+14.23%
3 months-11.36%
6 months+10.33%
Current year-21.94%
1 week 85
Extreme 85
90
1 month 76
Extreme 76
104.95
Current year 67
Extreme 67
131.75
1 year 30.01
Extreme 30.01
131.75
3 years 23.51
Extreme 23.51
131.75
5 years 20.2
Extreme 20.2
131.75
10 years 10.3
Extreme 10.3
131.75
Manager TitleAgeSince
Director of Finance/CFO - 12/02/2016
Compliance Officer - 03/01/2020
Director TitleAgeSince
Chairman 71 14/10/2010
Director/Board Member 55 09/12/2012
Director/Board Member 63 19/12/2012
Change 5-day change 1-year change 3-year change Capi.($)
-1.12%+2.09%+113.59%+214.51% 6.26M
+0.04%+3.34%+53.32%+102.40% 1,028B
-0.09%+1.66%+53.24%+65.73% 651B
-0.02%+2.66%+18.65%+71.84% 466B
-1.22%+3.66%+34.59%+39.32% 346B
-0.79%+2.73%+17.73%+23.91% 266B
+0.58%+6.76%+10.58%+14.16% 259B
+1.55%+2.20%+35.12%+42.07% 208B
+0.79%+1.84%-27.55%-57.51% 191B
-0.52%+4.45%+31.57%+97.98% 186B
Average -0.08%+3.14%+34.08%+61.44% 360.17B
Weighted average by Cap. -0.04%+3.09%+34.84%+61.41%

Financials

2025 2026
Net sales 244M 2.54M 2.21M 2.09M 1.9M 3.56M 3.57M 25.05M 9.67M 124M 9.54M 9.33M 399M 472M 4.92M 4.29M 4.05M 3.68M 6.89M 6.92M 48.52M 18.72M 240M 18.48M 18.07M 772M
Net income -15.89M -166K -144K -136K -124K -232K -233K -1.63M -630K -8.08M -622K -608K -26M 176M 1.83M 1.6M 1.51M 1.37M 2.57M 2.58M 18.06M 6.97M 89.34M 6.88M 6.73M 287M
Net Debt -1.94M -20.19K -17.6K -16.62K -15.09K -28.28K -28.4K -199K -76.83K -985K -75.83K -74.15K -3.17M -96.98M -1.01M -881K -832K -756K -1.42M -1.42M -9.97M -3.85M -49.31M -3.8M -3.71M -159M
Logo Phaarmasia Limited
Phaarmasia Limited is an India-based company, which is primarily engaged in the manufacturing and sale of oral contraceptive pills (OCPs). The Company manufactures and markets oral contraceptive tablets with various therapeutic dosage combinations along with iron tablets for the Ministry of Health & Family Welfare and for exports. Its product categories include Hormone Products and Herbal Products. Its hormone products include Estradiol Valerate Tablets; Medroxyprogesterone Acetate Tablets; Cabergoline Tablets; Clomiphene Citrate Tablets; Levonorgestrel Tablet; Fluoxymesterone tablets; Liothyronine Sodium tablets; Oxandrolone tablets and others. Its herbal products include Smyle Herbal Toothpaste; Smyle Cough & Sore Throat Reliver and Smyle Mouth Ulcer Gel. Its injectables include Testosterone Cypionate Injection; Methenolone Enanthate Injection; Drostanolone, Testosterone and Trenbolone Inj, and Stanozolol Cypionate Inj.
Employees
47
Date Price Change Volume
18/09/26 ₹88.00 -1.12% 213
17/09/26 ₹89.00 -0.28% 620
16/09/26 ₹89.25 +5.00% 202
15/09/26 ₹85.00 -1.39% 876
  1. Stock Market
  2. Stocks
  3. PHRMASI6 Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!